Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of TIPS placement on pharmacokinetics in cirrhosis
NL-OMON48883Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of caffeine, warfarin, omeprazole, metoprolol and midazolam in Cirrhosis, sponsored by Amsterdam University Medical Center. Primary endpoint: Difference in area under the plasma concentration-time curve for each probe drug. Started Jun 2019; status: recruiting.
02
Drugs
caffeinewarfarinomeprazolemetoprololmidazolam
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on NL-OMON48883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48883.